Search

everythinglearnresearchcommunity

for

Search:↓

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Androgens can both increase and decrease hair growth in different parts of the body.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A new gene, JMJD1C, may affect testosterone levels in men.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.